Humoral and cellular immune response to influenza virus vaccination in aged humans View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-12

AUTHORS

Umberto Fagiolo, A. Amadori, E. Cozzi, R. Bendo, M. Lama, A. Douglas, G. Palù

ABSTRACT

Aging is characterized by an increased susceptibility to infectious diseases; influenza virus infection, which is easily managed by an intact immune system, represents a life-threatening disease in aged subjects. We studied 18 healthy aged subjects (>65 years of age), vaccinated yearly with conventional anti-influenza vaccine, and 9 healthy young volunteers (mean age 26 years), without previous anti-influenza vaccination, who were vaccinated with the conventional trivalent 1990 anti-influenza preparation. Six out of the 18 aged individuals received a second boost of the same vaccine about 4 months later. In all subjects, we analyzed the humoral response to type A and B influenza viruses and the influenza type A virus-specific CTL generation. Among the elderly population with a single vaccination, 6 and 5 subjects seroconverted against type A and type B influenza virus respectively. Young subjects seroconverted in 5 cases against type A, and in 5 cases against type B influenza virus. Seroconversion took place after the second vaccination in only one subject, and the antibody production was type A specific. Influenza type A virus-specific CTL activity was significantly lower in aged subjects, compared with the values observed in the young volunteers (p=0.017). The second vaccination partially restored this immunological impairment. These data clearly demonstrate that the elderly do not have the same ability as younger subjects to mount an antibody response, and generate influenza type A virus-specific CTL after conventional anti-influenza vaccination. Moreover, a double anti-influenza vaccination generates CTL activity levels comparable to young subjects, although it does not seem to substantially modify the antibody production. (Aging Clin. Exp. Res. 5: 451–458, 1993) More... »

PAGES

451-458

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf03324202

DOI

http://dx.doi.org/10.1007/bf03324202

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048786612

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8161577


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunity, Cellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization, Secondary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza A virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza B virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes, Cytotoxic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fagiolo", 
        "givenName": "Umberto", 
        "id": "sg:person.011273501214.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273501214.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Oncology, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Institute of Oncology, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amadori", 
        "givenName": "A.", 
        "id": "sg:person.0600652745.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600652745.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cozzi", 
        "givenName": "E.", 
        "id": "sg:person.01371533166.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371533166.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bendo", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Internal Medicine, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lama", 
        "givenName": "M.", 
        "id": "sg:person.0766420144.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766420144.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Virology and WHO Influenza Center National, Institute for Medical Research, Millhill, London, United Kingdom", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Division of Virology and WHO Influenza Center National, Institute for Medical Research, Millhill, London, United Kingdom"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Douglas", 
        "givenName": "A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Microbiology, University of Padova, Padova, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5608.b", 
          "name": [
            "Institute of Microbiology, University of Padova, Padova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pal\u00f9", 
        "givenName": "G.", 
        "id": "sg:person.01107666354.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107666354.73"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00916574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009621789", 
          "https://doi.org/10.1007/bf00916574"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-12", 
    "datePublishedReg": "1993-12-01", 
    "description": "Aging is characterized by an increased susceptibility to infectious diseases; influenza virus infection, which is easily managed by an intact immune system, represents a life-threatening disease in aged subjects. We studied 18 healthy aged subjects (>65 years of age), vaccinated yearly with conventional anti-influenza vaccine, and 9 healthy young volunteers (mean age 26 years), without previous anti-influenza vaccination, who were vaccinated with the conventional trivalent 1990 anti-influenza preparation. Six out of the 18 aged individuals received a second boost of the same vaccine about 4 months later. In all subjects, we analyzed the humoral response to type A and B influenza viruses and the influenza type A virus-specific CTL generation. Among the elderly population with a single vaccination, 6 and 5 subjects seroconverted against type A and type B influenza virus respectively. Young subjects seroconverted in 5 cases against type A, and in 5 cases against type B influenza virus. Seroconversion took place after the second vaccination in only one subject, and the antibody production was type A specific. Influenza type A virus-specific CTL activity was significantly lower in aged subjects, compared with the values observed in the young volunteers (p=0.017). The second vaccination partially restored this immunological impairment. These data clearly demonstrate that the elderly do not have the same ability as younger subjects to mount an antibody response, and generate influenza type A virus-specific CTL after conventional anti-influenza vaccination. Moreover, a double anti-influenza vaccination generates CTL activity levels comparable to young subjects, although it does not seem to substantially modify the antibody production. (Aging Clin. Exp. Res. 5: 451\u2013458, 1993)", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf03324202", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1030201", 
        "issn": [
          "1594-0667", 
          "1720-8319"
        ], 
        "name": "Aging Clinical and Experimental Research", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "anti-influenza vaccination", 
      "type B influenza virus", 
      "influenza type", 
      "aged subjects", 
      "young subjects", 
      "influenza virus", 
      "second vaccination", 
      "virus-specific CTL generation", 
      "virus-specific CTL activity", 
      "young volunteers", 
      "antibody production", 
      "anti-influenza vaccine", 
      "virus-specific CTL", 
      "life-threatening disease", 
      "influenza virus vaccination", 
      "intact immune system", 
      "influenza virus infection", 
      "cellular immune responses", 
      "healthy aged subjects", 
      "healthy young volunteers", 
      "type A", 
      "CTL generation", 
      "CTL activity", 
      "virus vaccination", 
      "single vaccination", 
      "same vaccine", 
      "immunological impairment", 
      "humoral response", 
      "antibody response", 
      "virus infection", 
      "immune response", 
      "aged humans", 
      "elderly population", 
      "vaccination", 
      "immune system", 
      "aged individuals", 
      "second boost", 
      "infectious diseases", 
      "activity levels", 
      "vaccine", 
      "virus", 
      "subjects", 
      "disease", 
      "volunteers", 
      "response", 
      "seroconversion", 
      "infection", 
      "CTL", 
      "impairment", 
      "months", 
      "cases", 
      "same ability", 
      "humans", 
      "population", 
      "susceptibility", 
      "individuals", 
      "types", 
      "aging", 
      "levels", 
      "activity", 
      "boost", 
      "production", 
      "ability", 
      "data", 
      "preparation", 
      "specifics", 
      "values", 
      "generation", 
      "place", 
      "system", 
      "conventional anti-influenza vaccine", 
      "previous anti-influenza vaccination", 
      "conventional trivalent 1990 anti-influenza preparation", 
      "trivalent 1990 anti-influenza preparation", 
      "anti-influenza preparation", 
      "B influenza virus", 
      "type A specific", 
      "A specific", 
      "conventional anti-influenza vaccination", 
      "double anti-influenza vaccination", 
      "CTL activity levels"
    ], 
    "name": "Humoral and cellular immune response to influenza virus vaccination in aged humans", 
    "pagination": "451-458", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048786612"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf03324202"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8161577"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf03324202", 
      "https://app.dimensions.ai/details/publication/pub.1048786612"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T17:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_241.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf03324202"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf03324202'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf03324202'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf03324202'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf03324202'


 

This table displays all metadata directly associated to this object as RDF triples.

250 TRIPLES      22 PREDICATES      123 URIs      113 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf03324202 schema:about N0121b14130344a3792e46f159c688bb0
2 N39e97d4638554fd5a5f4d892f54a0ab8
3 N494e8f5256e042ba9ce6c98c26227ccc
4 N52312322c1a04e89a83f92d06504ce98
5 N6aebfeb8e0414d099611dab407cec872
6 N8d9269aa34854608bf0d3765bec7ba2d
7 N9c0da67221eb4e55ab6f0a057a14cedc
8 Na40cd1808bba497098a3aec3775386be
9 Nbfae6208cfc3479abf4579dac7d103e4
10 Ncb96edda7c824e33a19b5c7c828d841d
11 Ncf0eaacdceb04d66aae7cc0ab161047c
12 Ndc04cd7560114af697e9c97749d8895b
13 Nfbdb4f7fe4464393a272a551cd5c0f58
14 anzsrc-for:11
15 anzsrc-for:1103
16 anzsrc-for:1107
17 schema:author N5ae1b4f6bd3c48aebc0770a6f67b57c7
18 schema:citation sg:pub.10.1007/bf00916574
19 schema:datePublished 1993-12
20 schema:datePublishedReg 1993-12-01
21 schema:description Aging is characterized by an increased susceptibility to infectious diseases; influenza virus infection, which is easily managed by an intact immune system, represents a life-threatening disease in aged subjects. We studied 18 healthy aged subjects (>65 years of age), vaccinated yearly with conventional anti-influenza vaccine, and 9 healthy young volunteers (mean age 26 years), without previous anti-influenza vaccination, who were vaccinated with the conventional trivalent 1990 anti-influenza preparation. Six out of the 18 aged individuals received a second boost of the same vaccine about 4 months later. In all subjects, we analyzed the humoral response to type A and B influenza viruses and the influenza type A virus-specific CTL generation. Among the elderly population with a single vaccination, 6 and 5 subjects seroconverted against type A and type B influenza virus respectively. Young subjects seroconverted in 5 cases against type A, and in 5 cases against type B influenza virus. Seroconversion took place after the second vaccination in only one subject, and the antibody production was type A specific. Influenza type A virus-specific CTL activity was significantly lower in aged subjects, compared with the values observed in the young volunteers (p=0.017). The second vaccination partially restored this immunological impairment. These data clearly demonstrate that the elderly do not have the same ability as younger subjects to mount an antibody response, and generate influenza type A virus-specific CTL after conventional anti-influenza vaccination. Moreover, a double anti-influenza vaccination generates CTL activity levels comparable to young subjects, although it does not seem to substantially modify the antibody production. (Aging Clin. Exp. Res. 5: 451–458, 1993)
22 schema:genre article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N7fa661c90e264c95834bc650a3ab30ee
26 N9c17bd0ff0314c69a24465924be1f2d6
27 sg:journal.1030201
28 schema:keywords A specific
29 B influenza virus
30 CTL
31 CTL activity
32 CTL activity levels
33 CTL generation
34 ability
35 activity
36 activity levels
37 aged humans
38 aged individuals
39 aged subjects
40 aging
41 anti-influenza preparation
42 anti-influenza vaccination
43 anti-influenza vaccine
44 antibody production
45 antibody response
46 boost
47 cases
48 cellular immune responses
49 conventional anti-influenza vaccination
50 conventional anti-influenza vaccine
51 conventional trivalent 1990 anti-influenza preparation
52 data
53 disease
54 double anti-influenza vaccination
55 elderly population
56 generation
57 healthy aged subjects
58 healthy young volunteers
59 humans
60 humoral response
61 immune response
62 immune system
63 immunological impairment
64 impairment
65 individuals
66 infection
67 infectious diseases
68 influenza type
69 influenza virus
70 influenza virus infection
71 influenza virus vaccination
72 intact immune system
73 levels
74 life-threatening disease
75 months
76 place
77 population
78 preparation
79 previous anti-influenza vaccination
80 production
81 response
82 same ability
83 same vaccine
84 second boost
85 second vaccination
86 seroconversion
87 single vaccination
88 specifics
89 subjects
90 susceptibility
91 system
92 trivalent 1990 anti-influenza preparation
93 type A
94 type A specific
95 type B influenza virus
96 types
97 vaccination
98 vaccine
99 values
100 virus
101 virus infection
102 virus vaccination
103 virus-specific CTL
104 virus-specific CTL activity
105 virus-specific CTL generation
106 volunteers
107 young subjects
108 young volunteers
109 schema:name Humoral and cellular immune response to influenza virus vaccination in aged humans
110 schema:pagination 451-458
111 schema:productId N53409100bbad422db6f1f972de5cb4c8
112 N7efcc51e6acc480985a0565dee8e27d9
113 Nb5348f3a0ab24a7b9a255077fc71f5fd
114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048786612
115 https://doi.org/10.1007/bf03324202
116 schema:sdDatePublished 2021-11-01T17:59
117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
118 schema:sdPublisher N8e33761d5dd34c3f9ee97df80ef229ad
119 schema:url https://doi.org/10.1007/bf03324202
120 sgo:license sg:explorer/license/
121 sgo:sdDataset articles
122 rdf:type schema:ScholarlyArticle
123 N0121b14130344a3792e46f159c688bb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Influenza Vaccines
125 rdf:type schema:DefinedTerm
126 N0d2f347b2bc74020b469ffba02f26747 rdf:first sg:person.0600652745.06
127 rdf:rest N5a0fdb65a1a64846b952d9bf440bd794
128 N39e97d4638554fd5a5f4d892f54a0ab8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name T-Lymphocytes, Cytotoxic
130 rdf:type schema:DefinedTerm
131 N494e8f5256e042ba9ce6c98c26227ccc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Aged, 80 and over
133 rdf:type schema:DefinedTerm
134 N5201b2c15e314493b7190c8be2e6eeb7 rdf:first sg:person.0766420144.47
135 rdf:rest Nbaa198d69f7f4ecbae60e212a13ad8df
136 N52312322c1a04e89a83f92d06504ce98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Influenza A virus
138 rdf:type schema:DefinedTerm
139 N53409100bbad422db6f1f972de5cb4c8 schema:name doi
140 schema:value 10.1007/bf03324202
141 rdf:type schema:PropertyValue
142 N5a0fdb65a1a64846b952d9bf440bd794 rdf:first sg:person.01371533166.14
143 rdf:rest N7cf72b0e6f4a45648847f4492fc69350
144 N5ae1b4f6bd3c48aebc0770a6f67b57c7 rdf:first sg:person.011273501214.58
145 rdf:rest N0d2f347b2bc74020b469ffba02f26747
146 N6aebfeb8e0414d099611dab407cec872 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Humans
148 rdf:type schema:DefinedTerm
149 N7cf72b0e6f4a45648847f4492fc69350 rdf:first Nd5c370d50f1f4cd796a17d317c1c13b7
150 rdf:rest N5201b2c15e314493b7190c8be2e6eeb7
151 N7efcc51e6acc480985a0565dee8e27d9 schema:name dimensions_id
152 schema:value pub.1048786612
153 rdf:type schema:PropertyValue
154 N7fa661c90e264c95834bc650a3ab30ee schema:issueNumber 6
155 rdf:type schema:PublicationIssue
156 N8898de07d6264321b88c9eafe4794aa9 schema:affiliation grid-institutes:None
157 schema:familyName Douglas
158 schema:givenName A.
159 rdf:type schema:Person
160 N8d9269aa34854608bf0d3765bec7ba2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Influenza B virus
162 rdf:type schema:DefinedTerm
163 N8e33761d5dd34c3f9ee97df80ef229ad schema:name Springer Nature - SN SciGraph project
164 rdf:type schema:Organization
165 N9c0da67221eb4e55ab6f0a057a14cedc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Antibodies, Viral
167 rdf:type schema:DefinedTerm
168 N9c17bd0ff0314c69a24465924be1f2d6 schema:volumeNumber 5
169 rdf:type schema:PublicationVolume
170 Na40cd1808bba497098a3aec3775386be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Adult
172 rdf:type schema:DefinedTerm
173 Nb5348f3a0ab24a7b9a255077fc71f5fd schema:name pubmed_id
174 schema:value 8161577
175 rdf:type schema:PropertyValue
176 Nbaa198d69f7f4ecbae60e212a13ad8df rdf:first N8898de07d6264321b88c9eafe4794aa9
177 rdf:rest Nd2017bf8f5b54f849e731ec37aa0729f
178 Nbfae6208cfc3479abf4579dac7d103e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Time Factors
180 rdf:type schema:DefinedTerm
181 Ncb96edda7c824e33a19b5c7c828d841d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Immunization, Secondary
183 rdf:type schema:DefinedTerm
184 Ncf0eaacdceb04d66aae7cc0ab161047c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Aged
186 rdf:type schema:DefinedTerm
187 Nd2017bf8f5b54f849e731ec37aa0729f rdf:first sg:person.01107666354.73
188 rdf:rest rdf:nil
189 Nd5c370d50f1f4cd796a17d317c1c13b7 schema:affiliation grid-institutes:None
190 schema:familyName Bendo
191 schema:givenName R.
192 rdf:type schema:Person
193 Ndc04cd7560114af697e9c97749d8895b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Aging
195 rdf:type schema:DefinedTerm
196 Nfbdb4f7fe4464393a272a551cd5c0f58 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Immunity, Cellular
198 rdf:type schema:DefinedTerm
199 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
200 schema:name Medical and Health Sciences
201 rdf:type schema:DefinedTerm
202 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
203 schema:name Clinical Sciences
204 rdf:type schema:DefinedTerm
205 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
206 schema:name Immunology
207 rdf:type schema:DefinedTerm
208 sg:journal.1030201 schema:issn 1594-0667
209 1720-8319
210 schema:name Aging Clinical and Experimental Research
211 schema:publisher Springer Nature
212 rdf:type schema:Periodical
213 sg:person.01107666354.73 schema:affiliation grid-institutes:grid.5608.b
214 schema:familyName Palù
215 schema:givenName G.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107666354.73
217 rdf:type schema:Person
218 sg:person.011273501214.58 schema:affiliation grid-institutes:None
219 schema:familyName Fagiolo
220 schema:givenName Umberto
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273501214.58
222 rdf:type schema:Person
223 sg:person.01371533166.14 schema:affiliation grid-institutes:None
224 schema:familyName Cozzi
225 schema:givenName E.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371533166.14
227 rdf:type schema:Person
228 sg:person.0600652745.06 schema:affiliation grid-institutes:None
229 schema:familyName Amadori
230 schema:givenName A.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600652745.06
232 rdf:type schema:Person
233 sg:person.0766420144.47 schema:affiliation grid-institutes:None
234 schema:familyName Lama
235 schema:givenName M.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766420144.47
237 rdf:type schema:Person
238 sg:pub.10.1007/bf00916574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009621789
239 https://doi.org/10.1007/bf00916574
240 rdf:type schema:CreativeWork
241 grid-institutes:None schema:alternateName Department of Internal Medicine, Italy
242 Division of Virology and WHO Influenza Center National, Institute for Medical Research, Millhill, London, United Kingdom
243 Institute of Oncology, Italy
244 schema:name Department of Internal Medicine, Italy
245 Division of Virology and WHO Influenza Center National, Institute for Medical Research, Millhill, London, United Kingdom
246 Institute of Oncology, Italy
247 rdf:type schema:Organization
248 grid-institutes:grid.5608.b schema:alternateName Institute of Microbiology, University of Padova, Padova, Italy
249 schema:name Institute of Microbiology, University of Padova, Padova, Italy
250 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...